First Trust Advisors LP Has $23.68 Million Position in Humana Inc. (NYSE:HUM)

First Trust Advisors LP lifted its stake in Humana Inc. (NYSE:HUM - Free Report) by 78.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 93,328 shares of the insurance provider's stock after purchasing an additional 41,070 shares during the quarter. First Trust Advisors LP owned 0.08% of Humana worth $23,678,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in HUM. Vanguard Group Inc. raised its position in Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after acquiring an additional 1,751,857 shares in the last quarter. Dodge & Cox grew its holdings in Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares during the last quarter. Pzena Investment Management LLC grew its holdings in Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after purchasing an additional 1,103,132 shares during the last quarter. Geode Capital Management LLC grew its holdings in Humana by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock valued at $729,658,000 after purchasing an additional 63,562 shares during the last quarter. Finally, Invesco Ltd. grew its holdings in Humana by 29.8% during the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after purchasing an additional 550,692 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Price Performance

Humana stock traded up $2.20 during trading hours on Wednesday, hitting $261.56. 2,312,359 shares of the stock were exchanged, compared to its average volume of 1,752,795. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $31.57 billion, a P/E ratio of 26.29, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The business's 50-day moving average is $266.05 and its two-hundred day moving average is $270.76.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The company's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $7.23 earnings per share. Equities research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.35%. Humana's dividend payout ratio (DPR) is currently 35.58%.

Analysts Set New Price Targets

HUM has been the topic of several analyst reports. Barclays increased their price target on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Guggenheim began coverage on Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target on the stock. Mizuho upped their target price on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. StockNews.com raised shares of Humana from a "hold" rating to a "buy" rating in a report on Monday, April 7th. Finally, Piper Sandler upped their price objective on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $284.90.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.